Immunotherapy News and Research

Latest Immunotherapy News and Research

Scientists reveal direct link between mitochondrial DNA mutations and cancer treatment response

Scientists reveal direct link between mitochondrial DNA mutations and cancer treatment response

Blood chip could offer early insights into cancer treatment effectiveness

Blood chip could offer early insights into cancer treatment effectiveness

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

Immunotherapy drug extends overall survival in kidney cancer patients after surgery

Immunotherapy drug extends overall survival in kidney cancer patients after surgery

Research upends understanding of circadian clock in melanoma

Research upends understanding of circadian clock in melanoma

A certain type of chemotherapy found to improve the immune system's ability to fight off bladder cancer

A certain type of chemotherapy found to improve the immune system's ability to fight off bladder cancer

New insights into why immunotherapy works for some cancers, not others

New insights into why immunotherapy works for some cancers, not others

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

New workflow identifies shared cancer targets, advancing immunotherapy

New workflow identifies shared cancer targets, advancing immunotherapy

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

COST Action bridges the gap in cancer immunotherapy research

COST Action bridges the gap in cancer immunotherapy research

Ludwig scientists deconstruct the blood supply of brain metastases

Ludwig scientists deconstruct the blood supply of brain metastases

Annexin-A1 targeted therapy beats several cancers

Annexin-A1 targeted therapy beats several cancers

New targeted therapy eliminates cancer with zero side effects

New targeted therapy eliminates cancer with zero side effects

New bioengineered strategy shows potential for treating ulcerative colitis

New bioengineered strategy shows potential for treating ulcerative colitis

Innovative computational tool unearths hidden cancer targets for immunotherapy

Innovative computational tool unearths hidden cancer targets for immunotherapy

RBMX protein emerges as key player in cancer progression and immunotherapy response

RBMX protein emerges as key player in cancer progression and immunotherapy response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.